PTK7 and non-small cell lung carcinoma: In addition to the two cancer types studied above, PTK7 overexpression has been identified in a variety of other malignancies, including CRC, NSCLC, and OVCA.17,20,29 Consequently, we also investigated the antitumor efficacy of Sgc8c-M in these specific cancer types.